BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS Share Price

Certificat

DB79S

DE000SV1L3K1

Real-time Euronext Paris 08:17:36 14/05/2024 BST
5.965 EUR -7.20% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS
Current month+11.91%
1 month+1.44%
Date Price Change Volume
14/05/24 5.965 -7.20% 4
13/05/24 6.428 +3.24% 98
10/05/24 6.226 +3.25% 100
09/05/24 6.03 +1.52% 103
08/05/24 5.94 +0.93% 103

Real-time Euronext Paris

Last update May 14, 2024 at 08:17 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
DB79S
ISINDE000SV1L3K1
Date issued 01/03/2023
Strike 165.1 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 11.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.71
Lowest since issue 5.046

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
227.8 CHF
Average target price
279.4 CHF
Spread / Average Target
+22.65%
Consensus
  1. Stock Market
  2. Certificates
  3. DB79S Certificat